Iovance Biotherapeutics, Inc. Equity-NMS: IOVA

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$3.25
Open :$3.18
Today's high :$3.2
Today's low :$2.95
52W low :$2.95
52W high :$14.23
EPS(TTM): :-1.28
Shares O/S :327.88 M
Market cap :983.63 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Iovance Biotherapeutics, Inc. $3 -0.01% - 983.63M

Frequently Asked Questions

What is the share price of Iovance Biotherapeutics, Inc. today?

Iovance Biotherapeutics, Inc. (IOVA) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops and delivers tumor infiltrating lymphocyte (TIL), therapies for patients with solid tumor cancers. Its lead product candidate, Amtagvi (lifileucel), is a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor. The Company also marketing Proleukin (aldesleukin), aninterleukin-2, or IL-2, product used in the Amtagvi treatment regimen. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings for solid tumor cancers. Amtagvi and Proleukin are part of a treatment regimen that also includes lymphodepletion. The Company is also developing next generation therapies using TIL, such as genetically modified TIL cell therapy.